Barbara Cheifet - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Barbara Cheifet's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Barbara Cheifet
Verified
Chief Editor, Nature Biotechnology
New York
Beats
HEALTH SCIENCE
Content
By Barbara Cheifet Verified| Nature Verified In single-cell RNA sequencing (scRNA-seq), incorporation of multiple modalities in a single assay has become increasingly common. Looking at single-cell transcriptomics and proteomics simultaneously has led to increased knowledge regarding cellular states, developmental trajectories and identities.
By Barbara Cheifet Verified| Genome Biology Verified Genome Biology has built a reputation in the community for our strong data deposition policies [1]. We require our published methods and software to have their source code deposited on a public software repository, such as Github, and in a DOI-assigning repository, such as zenodo. The source code must also be released under an open source license compliant with OSI, and this must be clearly stated on the repository and in the manuscript.
By Barbara Cheifet Verified| Nature Verified In single-cell RNA sequencing (scRNA-seq), incorporation of multiple modalities in a single assay has become increasingly common. Looking at single-cell transcriptomics and proteomics simultaneously has led to increased knowledge regarding cellular states, developmental trajectories and identities.
Company Info
Nature Biotechnology
London, England, United Kingdom
+44 20 7833 4000